title: Development of a novel treatment planning test for credentialing rotational intensity-modulated radiotherapy techniques in the UK.
abstract: OBJECTIVE
  The increasing use of tomotherapy and volumetric-modulated arc therapy in UK centres will result in more centres choosing to use this technology in a clinical trial setting. The Radiotherapy Trials Quality Assurance (RTTQA) group has developed a new procedure to integrate into the UK intensity-modulated radiotherapy (IMRT) credentialing programme to cover rotational IMRT delivery techniques.
  
  
  METHODS
  A planning test [three-dimensional treatment planning system (3DTPS)] was designed specifically for rotational IMRT techniques. The feasibility of using this test in the credentialing programme for rotational IMRT was validated by 10 experienced UK centres. The study included five centres using Varian RapidArc™ (RA) (Varian Medical Systems, Milpitas, CA), two using Elekta VMAT™ (VMAT) (Elekta Inc., Norcross, GA) and three using helical tomotherapy (HT) plans. Centres were asked to carry out their own in-house quality assurance (QA) for the plans submitted for this study. A survey was sent out to centres aiming to gather information on their experience in undertaking the exercise and their QA results.
  
  
  RESULTS
  All centres fulfilled the primary goal by achieving the dose constraints of the primary planning target volume and organ at risk. Seven centres (three RA, one VMAT and three HT plans) were able to fulfil the secondary goal. Among those seven centres, three centres (two RA and one VMAT plans) achieved the tertiary goal. The results of the survey indicated that the 3DTPS test is a clinically relevant and practical planning test to be used.
  
  
  CONCLUSIONS
  A planning test for rotational therapy techniques was developed for the RTTQA IMRT credentialing programme.
  
  
  CONCLUSIONS
  This study validated the feasibility of a 3DTPS test to be used as part of a credentialing programme for rotational IMRT techniques in the UK.
authors: Mount Vernon Cancer Centre, Northwood, UK. yatmantsang@nhs.net
authors: Y
authors: Y
authors: Tsang
authors: L
authors: L
authors: Ciurlionis
authors: C
authors: C
authors: Clark
authors: K
authors: K
authors: Venables
mesh_terms: D003406:Credentialing; D005240:Feasibility Studies; D006801:Humans; D010347:Patient Care Planning / Q000592:standards*; D019047:Phantoms, Imaging; D011879:Radiotherapy Dosage; D050397:Radiotherapy, Intensity-Modulated / Q000592:standards*; D036542:Tomography, Spiral Computed; D006113:United Kingdom
references: Med Phys. 2009 Nov;36(11):5359-73
references: 19994544
references: Radiother Oncol. 2009 Oct;93(1):102-8
references: 19596158
references: Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):880-914
references: 11704310
references: J Appl Clin Med Phys. 2007 Jul 17;8(3):76-90
references: 17712302
references: Radiother Oncol. 2002 Oct;65(1):53-70
references: 12413675
references: Radiother Oncol. 2002 Mar;62(3):309-19
references: 12175562
references: J Natl Cancer Inst. 2008 Mar 5;100(5):300-7
references: 18314476
references: Int J Radiat Oncol Biol Phys. 2008;71(1 Suppl):S71-5
references: 18406942
references: Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1257-9; author reply 1259-61
references: 15234063
references: J Clin Oncol. 2010 Jun 20;28(18):2996-3001
references: 20479390
references: Radiother Oncol. 1995 Jul;36(1):1-8
references: 8525020
references: Radiother Oncol. 1993 Nov;29(2):81-4
references: 8310157